Purpose and Summary
Introduced on January 26, 2023, by Representative French
Hill, H.R. 555, the Securing America's Vaccines for Emergencies
Act of 2023 (SAVE Act), would amend sections of the Defense
Production Act (DPA) (50 U.S.C. Sec. 4501-4568) to authorize
the President to make payments to manufacturers to ensure the
availability of medical materials important to the national
defense. It would also require the President to submit a
strategy to Congress that includes (1) a plan to use
authorities under the Defense Production Act of 1950 to ensure
the supply of medical materials essential to the national
defense; and (2) plans to diversify, and address
vulnerabilities in, supply chains for essential medical
materials. Finally, it requires the President to submit to
Congress annual progress reports through FY2025 evaluating the
implementation of the strategy. By limiting the strategy to
national defense, the SAVE Act would also help prevent the DPA
from being abused for unrelated purposes. Further, the SAVE Act
would require any strategy to consider potential tradeoffs
between DPA and risks to U.S. competitiveness and innovation.
These considerations will help the U.S. be better prepared for
future emergencies that undermine national security.
Background and Need for Legislation
The DPA allows the President to require companies to
prioritize and accept contracts to meet national defense
requirements. The DPA also allows for the President to
incentivize production through loans, loan guarantees, and
purchase commitments. The COVID-19 pandemic underscored the
potential for infectious disease to undermine U.S. national
security interests. Together with Operation Warp Speed, the
previous Administration used the DPA 18 times to accelerate the
delivery of COVID-19 therapeutics and related equipment. The
DPA allowed the Administration to prioritize contracts with
medical suppliers. While the previous Administration's
invocation of the DPA was welcomed during the pandemic, there
is no broader government strategy on the appropriate use of the
DPA to address critical health emergencies, including its use
to diversify medical supply chains away from China. This lack
of clarity was the impetus for the SAVE Act.
HEARING
Pursuant to clause 3(c)(6) of rule XIII, the following
hearing was used to develop H.R. 555: The Committee on
Financial Services held a hearing on February 7, 2023, titled:
``Combatting the Economic Threat from China.''
Committee Consideration
The Committee on Financial Services met in open session on
February 28, 2023, and ordered H.R. 555 to be reported
favorably to the House as amended by a recorded vote of 33 ayes
to 1 nay (Record vote no. FC-22), a quorum being present.
Before the question was called to order the bill favorably
reported, the Committee adopted an amendment in the nature of a
substitute offered by Mr. Hill by voice vote.
Committee Votes
Clause 3(b) of rule XIII of the Rules of the House of
Representatives requires the Committee to list the record votes
on the order to report legislation and amendments thereto. H.R.
555 was ordered favorably reported to the House as amendment by
a recorded vote of 33 ayes to 1 nay (Record vote no. FC-22), a
quorum being present.
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
COMMITTEE OVERSIGHT FINDINGS
Pursuant to clause 3(c) of rule XIII of the Rules of the
House of Representatives, the findings and recommendations of
the Committee based on oversight activities under clause
2(b)(1) of rule X of the Rules of the House of Representatives,
are incorporated in the descriptive portions of this report.
PERFORMANCE GOALS AND OBJECTIVES
Pursuant to clause 3(c)(4) of rule XIII of the Rules of the
House of Representatives, the goal of H.R. 555 is to help the
U.S. be better prepared for future emergencies that undermine
national security.
CONGRESSIONAL BUDGET OFFICE ESTIMATES
Pursuant to clause 3(d)(1) of House rule XIII, the
Committee adopts as its own the cost estimate prepared by the
Director of the Congressional Budget Office pursuant to section
402 of the Congressional Budget Act of 1974.
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY, AND TAX
EXPENDITURES
Pursuant to clause 3(c)(2) of rule XIII of the Rules of the
House of Representatives, the Committee adopts as its own the
estimate of new budget authority, entitlement authority, or tax
expenditures or revenues contained in the cost estimate
prepared by the Director of the Congressional Budget Office
pursuant to section 402 of the Congressional Budget Act of
1973.
FEDERAL MANDATES STATEMENT
Pursuant to section 423 of the Unfunded Mandates Reform
Act, the Committee adopts as its own the estimate of the
Federal mandates prepared by the Director of the Congressional
Budget Office.
ADVISORY COMMITTEE STATEMENT
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
APPLICABILITY TO LEGISLATIVE BRANCH
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
EARMARK IDENTIFICATION
Pursuant to clause 9 of rule XXI of the Rules of the House
of Representatives, the Committee has carefully reviewed the
provisions of the bill and states that the provisions of the
bill do not contain any congressional earmarks, limited tax
benefits, or limited tariff benefits within the meaning of the
rule.
DUPLICATION OF FEDERAL PROGRAMS
Pursuant to clause 3(c)(5) of rule XIII of the Rules of the
House of Representatives, the Committee states that no
provision of the bill establishes or reauthorizes a program of
the Federal Government known to be duplicative of another
Federal program, including any program that was included in a
report to Congress pursuant to section 21 of the Public Law
111-139 or the most recent Catalog of Federal Domestic
Assistance.
SECTION-BY-SECTION ANALYSIS OF THE LEGISLATION
Sec. 1: Short title
This Act may be cited as the ``Securing America's Vaccines
for Emergencies Act of 2023'' or the ``SAVE Act of 2023''.
Sec. 2: Securing essential medical materials
This Section amends the DPA's statement of policy to
specify the availability of medical materials is essential to
national defense.
Sec. 3: Investment in supply chain security
This Section requires the President to submit a strategy to
employ the DPA to secure medical supplies essential for
national defense, identify vulnerabilities to the medical
supply chain, and work to diversify the supply chain so that
key elements are not under the exclusive control of adversarial
governments. Finally, the bill requires progress updates to
Congress on implementation of the strategy.
[all]